The Trump Administration may have offered a German biopharmaceutical firm working on a vaccine against SARS-CoV-2, the virus behind the COVID-19 pandemic, a large sum of money for the exclusive right to the vaccine, the Guardian reports.
The Trump Administration may have offered a German biopharmaceutical firm working on a vaccine against SARS-CoV-2, the virus behind the COVID-19 pandemic, a large sum of money for the exclusive right to the vaccine, the Guardian reports.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.